Oppenheimer Asset Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.58M Buy
108,417
+12,414
+13% +$867K 0.09% 258
2025
Q1
$7.06M Sell
96,003
-6,628
-6% -$487K 0.09% 251
2024
Q4
$6.72M Buy
102,631
+10,653
+12% +$698K 0.08% 265
2024
Q3
$7.17M Buy
91,978
+3,359
+4% +$262K 0.09% 247
2024
Q2
$6.91M Buy
88,619
+1,203
+1% +$93.8K 0.09% 251
2024
Q1
$5.92M Sell
87,416
-553
-0.6% -$37.5K 0.09% 254
2023
Q4
$5.92M Buy
87,969
+15,107
+21% +$1.02M 0.08% 270
2023
Q3
$4.93M Buy
72,862
+22,977
+46% +$1.56M 0.08% 284
2023
Q2
$3.57M Buy
49,885
+6,090
+14% +$436K 0.05% 367
2023
Q1
$3.04M Buy
43,795
+7,725
+21% +$536K 0.05% 387
2022
Q4
$2.45M Sell
36,070
-1,284
-3% -$87.1K 0.04% 426
2022
Q3
$2.05M Buy
37,354
+936
+3% +$51.3K 0.04% 442
2022
Q2
$2.41M Sell
36,418
-7,714
-17% -$510K 0.04% 415
2022
Q1
$2.93M Buy
44,132
+4,194
+11% +$278K 0.04% 419
2021
Q4
$2.33M Sell
39,938
-2,274
-5% -$132K 0.03% 509
2021
Q3
$2.54M Buy
42,212
+18,960
+82% +$1.14M 0.04% 457
2021
Q2
$1.39M Buy
+23,252
New +$1.39M 0.02% 649
2020
Q4
Sell
-12,917
Closed -$708K 1136
2020
Q3
$708K Sell
12,917
-21,777
-63% -$1.19M 0.01% 713
2020
Q2
$1.84M Sell
34,694
-8,188
-19% -$433K 0.04% 426
2020
Q1
$1.92M Sell
42,882
-38,462
-47% -$1.72M 0.05% 363
2019
Q4
$4.06M Sell
81,344
-52,809
-39% -$2.63M 0.09% 265
2019
Q3
$5.98M Sell
134,153
-70,550
-34% -$3.15M 0.13% 192
2019
Q2
$8.45M Buy
204,703
+941
+0.5% +$38.8K 0.19% 135
2019
Q1
$8.24M Sell
203,762
-4,714
-2% -$191K 0.19% 136
2018
Q4
$7.92M Sell
208,476
-16,995
-8% -$645K 0.2% 117
2018
Q3
$8.92M Sell
225,471
-244,229
-52% -$9.66M 0.2% 128
2018
Q2
$16.5M Buy
469,700
+7,895
+2% +$277K 0.4% 57
2018
Q1
$16.1M Buy
461,805
+37,416
+9% +$1.31M 0.41% 54
2017
Q4
$14.4M Hold
424,389
0.38% 60
2017
Q3
$14.4M Buy
424,389
+36,886
+10% +$1.25M 0.37% 61
2017
Q2
$13.2M Buy
387,503
+917
+0.2% +$31.3K 0.37% 63
2017
Q1
$12M Buy
+386,586
New +$12M 0.34% 73